Replies to post #10620 on Cytodyn Inc (CYDY)

[buckysherm]

That's right (although your buyout/mileage may vary) but you said EARNINGS not revenues.

[Bud Fox II]

That does make sense! But for the sake of argument; if CytoDyn was to manufacture market and ultimately sell to the end user each billion in revenues (at a 75% net revenue profit) at a 10 times PE would be $30 per share. Since the growth potential would be higher than 1 billion the PE would be much higher!! I need to reiterate , that 44% of the HIV infected patients that are not on any treatment, I feel that PRO 140 could fill this void and represent at least a $10B market potential. Gilead would love to swoop in and take that market but they can't with there toxic HAART therapies! PRO 140 can!!